nach oben

Erschienen in:

19.06.2017 | Original Paper

The significance of TIMD4 expression in clear cell renal cell carcinoma

verfasst von: Hiromu Yano, Takanobu Motoshima, Chaoya Ma, Cheng Pan, Sohsuke Yamada, Toshiyuki Nakayama, Shohei Kitada, Naohiro Fujimoto, Tomomi Kamba, Motohiro Takeya, Yoshihiro Komohara

Erschienen in: Medical Molecular Morphology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

T-cell immunoglobulin and mucin domain (TIMD) family genes are related to innate immune responses. TIMD4 is a receptor for phosphatidylserine and is involved in the phagocytosis of apoptotic cells by macrophages. In the present study, we found that TIMD4 is expressed on the cancer cells of patients with clear cell renal cell carcinoma (ccRCC). TIMD4 was immunostained in the resected samples of 89 patients diagnosed as ccRCC. High expression of TIMD4 in cancer cells was closely related to short progression free survival time; however, it was not correlated with other clinicopathological factors. Intracellular expression of TIMD4 was observed in the RCC cell line, 786-O. In vitro studies using 786-O cells and shRNA targeting TIMD4 indicated that TIMD4 expression was associated with resistance to sorafenib but not with cell proliferation. TIMD4 might be useful as a prognostic factor and may also be a new target for therapy of ccRCC.

Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH (2010) TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev 235:172–189CrossRefPubMedPubMedCentral

Kuchroo VK, Dardalhon V, Xiao S, Anderson AC (2008) New roles for TIM family members in immune regulation. Nat Rev Immunol 8:577–580CrossRefPubMed

Cheng L, Ruan Z (2015) Tim-3 and Tim-4 as the potential targets for antitumor therapy. Hum Vaccin Immunother. 11:2458–2462CrossRefPubMedPubMedCentral

Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S (2007) Identification of Tim4 as a phosphatidylserine receptor. Nature 450:435–439CrossRefPubMed

Baghdadi M, Yoneda A, Yamashina T, Nagao H, Komohara Y, Nagai S, Akiba H, Foretz M, Yoshiyama H, Kinoshita I, Dosaka-Akita H, Takeya M, Viollet B, Yagita H, Jinushi M (2013) TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance. Immunity 39:1070–1081CrossRefPubMed

Baghdadi M, Jinushi M (2014) The impact of the TIM gene family on tumor immunity and immunosuppression. Cell Mol Immunol 11:41–48CrossRefPubMed

Nakai W, Yoshida T, Diez D, Miyatake Y, Nishibu T, Imawaka N, Naruse K, Sadamura Y, Hanayama R (2016) A novel affinity-based method for the isolation of highly purified extracellular vesicles. Sci Rep. 6:33935CrossRefPubMedPubMedCentral

Zhang Q, Wang H, Wu X, Liu B, Liu W, Wang R, Liang X, Ma C, Gao L (2015) TIM-4 promotes the growth of non-small-cell lung cancer in a RGD motif-dependent manner. Br J Cancer 113:1484–1492CrossRefPubMedPubMedCentral

Ma C, Komohara Y, Ohnishi K, Shimoji T, Kuwahara N, Sakumura Y, Matsuishi K, Fujiwara Y, Motoshima T, Takahashi W, Yamada S, Kitada S, Nakayama T, Eto M, Takeya M (2016) Infiltration of tumor-associated macrophages is involved in CD44 expression in clear cell renal cell carcinoma. Cancer Sci 107:700–707CrossRefPubMedPubMedCentral

10.

Komohara Y, Morita T, Annan DA, Horlad H, Ohnishi K, Yamada S, Nakayama T, Kitada S, Suzu S, Kinoshita I, Dosaka-Akita H, Akashi K, Takeya M, Jinushi M (2015) The coordinated actions of TIM-3 on cancer and myeloid cells in the regulation of tumorigenicity and clinical prognosis in clear cell renal cell carcinomas. Cancer Immunol Res 3:999–1007CrossRefPubMed

11.

Nakagawa T, Ohnishi K, Kosaki Y, Saito Y, Horlad H, Fujiwara Y, Takeya M, Komohara Y (2017) Optimum immunohistochemical procedures for analysis of macrophages in human and mouse formalin fixed paraffin-embedded tissue samples. In press, J Clin Exp Hematop

12.

Mikami S, Oya M, Mizuno R, Kosaka T, Katsube K, Okada Y (2014) Invasion and metastasis of renal cell carcinoma. Med Mol Morphol. 47:63–67CrossRefPubMed

13.

Kuroda N, Tanaka A (2014) Recent classification of renal epithelial tumors. Med Mol Morphol. 47:68–75CrossRefPubMed

14.

Kuroda N, Tanaka A, Ohe C, Nagashima Y (2013) Recent advances of immunohistochemistry for diagnosis of renal tumors. Pathol Int 63:381–390CrossRefPubMed

15.

Li W, Li X, Xu S, Ma X, Zhang Q (2016) Expression of Tim4 in glioma and its regulatory role in LN-18 glioma cells. Med Sci Monit 22:77–82CrossRefPubMedPubMedCentral

16.

Kovaleva OV, Samoilova DV, Shitova MS, Gratchev A (2016) Tumor associated macrophages in kidney cancer. Anal Cell Pathol (Amst) 2016:9307549

17.

Komohara Y, Jinushi M, Takeya M (2014) Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci 105:1–8CrossRefPubMed

18.

Komohara Y, Takeya M (2017) CAFs and TAMs: maestros of the tumour microenvironment. J Pathol 241:313–315CrossRefPubMed

19.

Heqing Y, Bin L, Xuemei Y, Linfa L (2016) The role and mechanism of autophagy in sorafenib targeted cancer therapy. Crit Rev Oncol Hematol 100:137–140CrossRefPubMed

20.

Kharaziha P, Chioureas D, Baltatzis G, Fonseca P, Rodriguez P, Gogvadze V, Lennartsson L, Björklund AC, Zhivotovsky B, Grandér D, Egevad L, Nilsson S, Panaretakis T (2015) Sorafenib-induced defective autophagy promotes cell death by necroptosis. Oncotarget 6:37066–37082CrossRefPubMedPubMedCentral

21.

Zhai B, Hu F, Jiang X, Xu J, Zhao D, Liu B, Pan S, Dong X, Tan G, Wei Z, Qiao H, Jiang H, Sun X (2014) Inhibition of Akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma. Mol Cancer Ther 13:1589–1598CrossRefPubMed

Titel: The significance of TIMD4 expression in clear cell renal cell carcinoma
verfasst von: Hiromu Yano
Takanobu Motoshima
Chaoya Ma
Cheng Pan
Sohsuke Yamada
Toshiyuki Nakayama
Shohei Kitada
Naohiro Fujimoto
Tomomi Kamba
Motohiro Takeya
Yoshihiro Komohara
Publikationsdatum: 19.06.2017
Verlag: Springer Japan
Erschienen in: Medical Molecular Morphology / Ausgabe 4/2017
Print ISSN: 1860-1480
Elektronische ISSN: 1860-1499
DOI: https://doi.org/10.1007/s00795-017-0164-9

Neu im Fachgebiet Pathologie

01.04.2024 | Forensische Traumatologie | CME

Springer Medizin

The significance of TIMD4 expression in clear cell renal cell carcinoma

Abstract

Neu im Fachgebiet Pathologie

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2017

Significance of evaluating tumor-infiltrating lymphocytes (TILs) and programmed cell death-ligand 1 (PD-L1) expression in breast cancer

Increased hepatic ABCA1 transporter is associated with hypercholesterolemia in a cholestatic rat model and primary biliary cholangitis patients

Hepatic progenitor cell expansion in early-stage nonalcoholic steatohepatitis: evidence from immunohistochemistry and immunoelectron microscopy of matrix metalloproteinase-1

Clinically relevant radioresistant cell line: a simple model to understand cancer radioresistance

Establishment of a tumor sphere cell line from a metastatic brain neuroendocrine tumor

Inclusion bodies of aggregated hemosiderins in liver macrophages

Neu im Fachgebiet Pathologie

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien